Image2_Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy.JPEG by Chaofeng Zhang (845343)

“…Background<p>CDGSH iron-sulfur domain 2 (CISD2), an iron-sulfur protein with a [2Fe-2S] cluster, plays a pivotal role in the progression of various cancers, including Diffuse Large B-cell Lymphoma (DLBCL). …”

Image_2_Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.jpeg by Qikai Zhang (6905096)

“…Background<p>With the unveiling of new mechanisms and the advent of new drugs, the prognosis of diffuse large B-cell lymphoma (DLBCL) becomes promising, but some patients still progress to the relapse or refractory stage. …”

Image_1_Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.jpeg by Qikai Zhang (6905096)

“…Background<p>With the unveiling of new mechanisms and the advent of new drugs, the prognosis of diffuse large B-cell lymphoma (DLBCL) becomes promising, but some patients still progress to the relapse or refractory stage. …”

Image_4_Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.jpeg by Qikai Zhang (6905096)

“…Background<p>With the unveiling of new mechanisms and the advent of new drugs, the prognosis of diffuse large B-cell lymphoma (DLBCL) becomes promising, but some patients still progress to the relapse or refractory stage. …”

Image_3_Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.jpeg by Qikai Zhang (6905096)

“…Background<p>With the unveiling of new mechanisms and the advent of new drugs, the prognosis of diffuse large B-cell lymphoma (DLBCL) becomes promising, but some patients still progress to the relapse or refractory stage. …”

Image_4_The gut microbiota correlate with the disease characteristics and immune status of patients with untreated diffuse large B-cell lymphoma.jpeg by Zhouning Lin (14648597)

“…Background<p>Gut microbiota characteristics in patients with diffuse large B-cell lymphoma (DLBCL) are reportedly different when compared with the healthy population and it remains unclear if the gut microbiota affects host immunity and clinical disease features. …”

Image_1_The gut microbiota correlate with the disease characteristics and immune status of patients with untreated diffuse large B-cell lymphoma.jpeg by Zhouning Lin (14648597)

“…Background<p>Gut microbiota characteristics in patients with diffuse large B-cell lymphoma (DLBCL) are reportedly different when compared with the healthy population and it remains unclear if the gut microbiota affects host immunity and clinical disease features. …”

Image_5_The gut microbiota correlate with the disease characteristics and immune status of patients with untreated diffuse large B-cell lymphoma.jpeg by Zhouning Lin (14648597)

“…Background<p>Gut microbiota characteristics in patients with diffuse large B-cell lymphoma (DLBCL) are reportedly different when compared with the healthy population and it remains unclear if the gut microbiota affects host immunity and clinical disease features. …”

Image_3_The gut microbiota correlate with the disease characteristics and immune status of patients with untreated diffuse large B-cell lymphoma.jpeg by Zhouning Lin (14648597)

“…Background<p>Gut microbiota characteristics in patients with diffuse large B-cell lymphoma (DLBCL) are reportedly different when compared with the healthy population and it remains unclear if the gut microbiota affects host immunity and clinical disease features. …”

Image_2_The gut microbiota correlate with the disease characteristics and immune status of patients with untreated diffuse large B-cell lymphoma.jpeg by Zhouning Lin (14648597)

“…Background<p>Gut microbiota characteristics in patients with diffuse large B-cell lymphoma (DLBCL) are reportedly different when compared with the healthy population and it remains unclear if the gut microbiota affects host immunity and clinical disease features. …”

19606 decreases the luminal pH of the ACV during infection. by Jesus S. Distel (11250759)

(a) Molds; (b) Samples; (c)(d) Test devices. by Chenhao Li (822769)

“…<div><p>To solve the disposal of large quantities of construction waste clay, this study proposes a new method for preparing controlled low strength materials (CLSM). …”

Excreted products from adult STAT6 KO -adapted worms have decreased immunogenicity. by Annabel A. Ferguson (17616286)

Summary estimate for the pooled PLR (A) and NLR (B) of MPV in the diagnosis of ITP. by Muluken Walle (13794209)

Adjusted association of demographic factors with SDOH scores among Arkansans overall and by race and ethnicity from September 5, 2020 to December 18, 2020^a^,<s... by Jenil R. Patel (3639451)

Relative Index of Inequality (RII) and 95% Confidence Interval (CI) for access question between most a least deprived SIMD decile by A) Age and sex B) Number of Health Issues and c... by David Henderson (4612354)

Relative Index of Inequality (RII) and 95% Confidence Interval (CI) for overall satisfaction between most a least deprived SIMD decile by A) Age and sex B) Number of Health Issues... by David Henderson (4612354)

CY-09 Alleviates the Depression-like Behaviors via Inhibiting NLRP3 Inflammasome-Mediated Neuroinflammation in Lipopolysaccharide-Induced Mice by Yu Wang (12152)

“…Depression is a serious mental illness, mainly characterized as large mood swings and sleep, diet, and cognitive function disorders. …”

Percentage of positive responses to overall satisfaction 2011/12 by A) Age and sex B) SIMD decile C) Number of Health Issues and D) Urban/Rural Class. by David Henderson (4612354)

Percentage of positive responses to access question 2011/12 by A) Age and sex B) SIMD decile C) Number of Health Issues and D) Urban/Rural Class. by David Henderson (4612354)